PAMLECTABART TISMANITIN
UNII CZ3K2AB2XK

Substance Identification & Data

This profile provides standardized clinical and technical data for Pamlectabart Tismanitin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CZ3K2AB2XK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2925692-67-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
CZ3K2AB2XK
CAS Registry Number
2925692-67-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PAMLECTABART TISMANITIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C179409
National Cancer Institute reference terminology for clinical and research data.
INN ID
13244
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pamlectabart Tismanitin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PAMLECTABART TISMANITIN

Common Names & Synonyms

IMMUNOGLOBULIN G1 (268-CYSTEINE), ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17) (HUMAN-MUS MUSCULUS MONOCLONAL J22.9-ISY .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL J22.9-ISY .KAPPA.-CHAIN, DIMER, 268,268'-BIS(THIOETHER) WITH 1-(N-((4-((N-(3-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOPROPYL)-L-VALYL-L-ALANYL)AMINO)PHENYL)METHYL)-L-ASPARAGINE)-4-(2-MERCAPTO-L-TRYPTOPHAN)-.ALPHA.-AMANITIN DE-S-OXIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF17 (TUMOR NECROSIS FACTOR (TNF) RECEPTOR SUPERFAMILY MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, TNFRSF13A, CD269)), HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED AT CYSTEINE RESIDUES 268 AND 268'' WITH TISMANITIN, COMPRISING A CLEAVABLE LINKER AND A SYNTHETIC .ALPHA.-AMANITIN DERIVATIVE
PAMLECTABART TISMANITIN [INN]

Technical Codes

J22.9-ISY-D265C-30.2115

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus